ReCon Chat with Bob...
Health Care: Drugs
Oncolytics Biotech Inc. (ONCY: NASDAQ)
$2.72 -0.03 | -1.09%
05/23/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with ONCY
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- UserASCO 2010
- Userrussbow98 Portfolio 1
- Userwallacee Portfolio 1
- UserASCO 2009 Nymph's Watch List.
- Userdoom-n-gloom
- Userutopian_holdings
- Userjohndboyle Portfolio 1
- UserDenverbill1027 Portfolio 1
Latest ONCY Headlines from TheStreet
- Biotech Stock Mailbag: MannKind, Ariad, Oncolytics Biotech 04.05.13 | 07:04 am
- Biotech Stock Mailbag: Ziopharm, Oncolytics, Sarepta 03.01.13 | 06:03 am
- Why Expect More Price Swings From These 4 Biotechs 02.28.13 | 11:02 am
- Stocks Finish Higher Ahead of Fed Decision 09.12.12 | 05:09 pm
- Biotech Stock Mailbag: Oncolytics, Sarepta, Delcath, Peregrine 08.24.12 | 06:08 am
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- BIO CEO Conference Live Blog 02.14.11 | 02:02 pm
- Amgen Makes Bet on Viral Skin Cancer Killer 01.26.11 | 10:01 am
- Biotech's Brighter Corners 12.08.10 | 12:12 pm
- Columbia Laboratories, Cardionet: Early Volume Plays 06.01.10 | 09:06 am
Press Releases for ONCY
- Oncolytics Biotech® Inc. Meets Primary Endpoint For First Stage Of U.S. Phase 2 Metastatic Melanoma Trial - PR Newswire 05.22.13 | 06:05 am
- Media Advisory - Oncolytics Biotech® Inc. To Present At Bank Of America Merrill Lynch Health Care Conference - PR Newswire 05.14.13 | 06:05 am
- Oncolytics Biotech® Inc. Announces Details Of 2013 Annual And Special Meeting Of Shareholders - PR Newswire 05.06.13 | 06:05 am
- Media Advisory - Oncolytics Biotech® Inc. To Present At 12th Annual Needham Healthcare Conference - PR Newswire 04.29.13 | 06:04 am
- Oncolytics Biotech® Inc. Meets Primary Overall Statistical Endpoint In U.S. Phase 2 Study Of REOLYSIN® In Squamous Cell Lung Cancer - PR Newswire 03.28.13 | 06:03 am
- Oncolytics Biotech® Inc. Completes Patient Enrollment In U.S. Phase 2 Study Of REOLYSIN® In Non-Small Cell Lung Cancer - PR Newswire 03.05.13 | 06:03 am
- Media Advisory - Oncolytics Biotech® Inc. To Present At RBC Capital Markets 2013 Healthcare Conference - PR Newswire 02.25.13 | 05:02 pm
- Oncolytics Biotech® Inc. Announces Closing Of Common Share Offering - PR Newswire 02.25.13 | 11:02 am
- Oncolytics Biotech® Inc. Announces Addition To Senior Management Team - PR Newswire 02.20.13 | 05:02 pm
- Oncolytics Biotech® Inc. Announces Pricing Of Common Share Offering - PR Newswire 02.20.13 | 09:02 am
Partner Headlines for ONCY
- Oncolytics Moves On A Hot Streak Of Clinical Data - Seeking Alpha 02.12.13 | 08:02 am
- 5 Stocks Under $5 On Winning Streaks - Seeking Alpha 01.05.13 | 05:01 am
- UPDATE: Stifel Nicolaus Initiates Oncolytics Ciotech at Buy with $6 PT on Reolysin Cancer Focus - Benzinga 08.30.12 | 01:08 pm
- Hyper-Novel Investments For Targeting Cancer - Seeking Alpha 05.30.12 | 09:05 am
- Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer - Seeking Alpha 10.25.11 | 08:10 am
- Company News for May 18, 2011 - Corporate Summary - Zacks 05.18.11 | 10:05 am
- Oncolytics Pushes Its Pipeline Further - Seeking Alpha 12.02.10 | 09:12 am
- Predictions for Biotech Data Heading to ASCO - Seeking Alpha 06.02.10 | 03:06 am
- Oncolytics Ready for Final Clinical Step With Reolysin - Seeking Alpha 05.20.10 | 10:05 am
